Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

New York ,United States ,Oregon ,Robert Andrade ,Lindsay Rocco ,Rosty Raykov ,Science University ,Fifty Sonesta Select Hotel ,Fennec Pharmaceuticals ,Fennec Pharmaceuticals Inc ,Oregon Health ,Nasdaq ,Exchange Commission ,Clinical Oncology Group Protocol ,Development Rd Expenses ,Company Has ,European Medicines Agency ,Elixir Health Public Relations ,Drug User Fee Act ,Target Action Date Set ,First Therapy ,Cisplatin Induced Hearing Loss ,Company Has Approximately ,Funded Debt ,Annual General Meeting ,Eden Room ,Third Avenue ,First Quarter ,New Drug Application ,Liability Data ,Marketing Authorization Application ,Breakthrough Therapy ,Fast Track Designation ,Orphan Drug Designation ,Obtaining Fast Track Designation ,Breakthrough Therapy Designation ,Annual Report ,Covid 19 ,Health ,Globe Newswire ,